CN107496176A - Safe and efficient antibacterial wet tissue and preparation method thereof - Google Patents
Safe and efficient antibacterial wet tissue and preparation method thereof Download PDFInfo
- Publication number
- CN107496176A CN107496176A CN201610414752.1A CN201610414752A CN107496176A CN 107496176 A CN107496176 A CN 107496176A CN 201610414752 A CN201610414752 A CN 201610414752A CN 107496176 A CN107496176 A CN 107496176A
- Authority
- CN
- China
- Prior art keywords
- solution
- antibacterial
- formula
- chitosan
- safe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 147
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 229920001661 Chitosan Polymers 0.000 claims abstract description 74
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 63
- 239000007788 liquid Substances 0.000 claims abstract description 59
- 239000008367 deionised water Substances 0.000 claims abstract description 42
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 42
- 239000004094 surface-active agent Substances 0.000 claims abstract description 21
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 93
- 238000003756 stirring Methods 0.000 claims description 38
- 238000006243 chemical reaction Methods 0.000 claims description 36
- 239000004475 Arginine Substances 0.000 claims description 34
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 34
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 33
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 20
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 239000007795 chemical reaction product Substances 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000012265 solid product Substances 0.000 claims description 4
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 150000008051 alkyl sulfates Chemical class 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 150000001805 chlorine compounds Chemical class 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 239000008236 heating water Substances 0.000 claims 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000005352 clarification Methods 0.000 claims 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims 1
- 238000009738 saturating Methods 0.000 claims 1
- RRLOOYQHUHGIRJ-UHFFFAOYSA-M sodium;ethyl sulfate Chemical compound [Na+].CCOS([O-])(=O)=O RRLOOYQHUHGIRJ-UHFFFAOYSA-M 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 18
- 231100000252 nontoxic Toxicity 0.000 abstract description 8
- 230000003000 nontoxic effect Effects 0.000 abstract description 8
- 239000003242 anti bacterial agent Substances 0.000 abstract description 5
- 230000007794 irritation Effects 0.000 abstract description 5
- 241000700605 Viruses Species 0.000 abstract description 4
- 244000005700 microbiome Species 0.000 abstract description 4
- 244000052616 bacterial pathogen Species 0.000 abstract description 3
- 230000009972 noncorrosive effect Effects 0.000 abstract description 2
- 231100000956 nontoxicity Toxicity 0.000 abstract description 2
- 239000000126 substance Substances 0.000 description 36
- 238000012360 testing method Methods 0.000 description 21
- 210000003491 skin Anatomy 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000000645 desinfectant Substances 0.000 description 17
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- 238000000502 dialysis Methods 0.000 description 9
- 238000005303 weighing Methods 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 206010040880 Skin irritation Diseases 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 231100000344 non-irritating Toxicity 0.000 description 8
- 231100000475 skin irritation Toxicity 0.000 description 8
- 230000036556 skin irritation Effects 0.000 description 8
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 7
- 239000004744 fabric Substances 0.000 description 5
- 229920000136 polysorbate Polymers 0.000 description 5
- 230000002110 toxicologic effect Effects 0.000 description 5
- 231100000027 toxicology Toxicity 0.000 description 5
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 206010070835 Skin sensitisation Diseases 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 238000003381 deacetylation reaction Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 231100000286 mucous membrane, eye irritation or corrosion testing Toxicity 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 231100000370 skin sensitisation Toxicity 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 241000539677 Berant virus Species 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 206010057385 Eyelid irritation Diseases 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 231100000067 mild irritant Toxicity 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000002602 strong irritant Substances 0.000 description 1
- 208000010731 swelling symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000942 weak sensitizer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Biomedical Technology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Dermatology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开一种安全高效的抗菌湿巾及其制备方法。所述抗菌湿巾由灭菌无纺布和负载于灭菌无纺布上的壳聚糖衍生物基抗菌液体组成,所述抗菌液体的负载量为50‑500wt%;所述抗菌液体包括如下重量份数的原料,以100重量份计:壳聚糖衍生物0.05‑5份,表面活性剂0.5‑5份,去离子水余量。本发明所述安全高效的抗菌湿巾由于采用了具有良好生物相容性、安全无毒无刺激、广谱抗菌性能的壳聚糖衍生物作为抗菌剂,可用于手、医疗器械、家庭日用品等物品表面的抗菌消毒,可有效杀灭常见致病细菌、病毒等有害微生物,且绿色环保、安全无毒无皮肤刺激性、无腐蚀,便于携带和使用。The invention discloses a safe and efficient antibacterial wet tissue and a preparation method thereof. The antibacterial wet wipes are composed of a sterilized nonwoven fabric and a chitosan derivative-based antibacterial liquid loaded on the sterilized nonwoven fabric, and the load of the antibacterial liquid is 50-500wt%; the antibacterial liquid includes the following Raw materials in parts by weight, based on 100 parts by weight: 0.05-5 parts of chitosan derivatives, 0.5-5 parts of surfactant, and the balance of deionized water. The safe and efficient antibacterial wet wipes of the present invention can be used for hands, medical equipment, household daily necessities, etc. due to the use of chitosan derivatives with good biocompatibility, safety, non-toxicity, non-irritation, and broad-spectrum antibacterial properties as antibacterial agents. The antibacterial disinfection of the surface of the article can effectively kill common pathogenic bacteria, viruses and other harmful microorganisms, and it is green, safe, non-toxic, non-skin irritating, non-corrosive, and easy to carry and use.
Description
技术领域technical field
本发明涉及日常清洁品及其制备领域。更具体地,涉及一种安全高效的抗菌湿巾及其制备方法。The invention relates to the field of daily cleaning products and their preparation. More specifically, it relates to a safe and efficient antibacterial wet wipe and a preparation method thereof.
背景技术Background technique
当前市场上的湿巾大致可以分为两类:一类是本身已经被消毒,但对其他物品没有抗菌保护作用,里面含有护肤的成分,只能做皮肤湿润保养的;另一类是不仅本身被消毒,而且对别的物品也可起到消毒作用的消毒湿巾,可以用做皮肤和日常生活用品的消毒或杀菌。The wet wipes currently on the market can be roughly divided into two categories: one type has been sterilized itself, but has no antibacterial protection effect on other items, and contains skin care ingredients, which can only be used for skin moisturizing and maintenance; the other type is not only for itself Disinfectant wipes that are disinfected and can also disinfect other items can be used for disinfection or sterilization of skin and daily necessities.
而消毒湿巾常用消毒剂主要有过氧乙酸、乙醇、异丙醇等,这些消毒剂各有优缺点。过氧乙酸为强氧化剂,有很强的氧化性,遇有机物放出新生态氧而起氧化作用,与次氯酸钠(又名84消毒液)、漂白粉等被作为医疗或生活消毒药物使用,为高效、速效、低毒、广谱杀菌剂,对细菌繁殖体、芽孢、病毒、霉菌均有杀灭作用。因此可用它来进行杀菌、消毒。此外,由于过氧乙酸在空气中具有较强的挥发性,对空气进行杀菌、消毒具有良好的效果,而且价格便宜,我国2003年在预防非典时的杀菌、消毒剂主要就是过氧乙酸。但过氧乙酸溶液不稳定,贮存时需置于通风阴凉处,用前先测定其有效浓度;用蒸馏水、去离子水或纯净水配制稀释液,稀释液常温下保存不宜超过48h。过氧乙酸对金属有很强的腐蚀性,有碱类或有机物混入时剧烈分解,甚至发生爆炸。高浓度的药液具有强腐蚀性和刺激性,而且其气味人很难接受。醇类消毒剂最常用的是乙醇和异丙醇,它可凝固蛋白质,导致微生物死亡,属于中效消毒剂,可杀灭细菌繁殖体,破坏多数亲脂性病毒,如单纯疱疹病毒、乙型肝炎病毒、人类免疫缺陷病毒等。但乙醇杀菌对浓度有一定要求,其有效体积分数应为65%~75%。水对乙醇发挥杀菌作用非常必要,因此用于消毒时需对乙醇进行稀释,但浓度低于30%时杀菌作用很小,浓度过强或过弱,杀菌作用都会降低。75%的单方乙醇消毒制剂对人体无毒,但由于人的体质不同,个别人对乙醇过敏,接触后可引起皮疹、红斑。乙醇消毒制剂经常使用,皮肤会因此而产生脱脂而干燥、粗糙等现象。异丙醇的杀菌作用强于乙醇,但其属于轻度有毒物质,超过一定浓度时,对呼吸道黏膜和眼结膜有强烈刺激作用,并可引起细胞组织坏死。异丙醇溶液溶脂性强,反复接触皮肤可使皮肤干燥脱脂。The commonly used disinfectants for disinfectant wipes mainly include peracetic acid, ethanol, isopropanol, etc. These disinfectants have their own advantages and disadvantages. Peracetic acid is a strong oxidizing agent with strong oxidizing properties. When it encounters organic matter, it releases new ecological oxygen to oxidize. It is used as a medical or life disinfection drug with sodium hypochlorite (also known as 84 disinfectant) and bleaching powder. It is highly effective and quick-acting. , low toxicity, broad-spectrum fungicide, has killing effect on bacterial propagules, spores, viruses and molds. Therefore, it can be used for sterilization and disinfection. In addition, because peracetic acid has strong volatility in the air, it has a good effect on sterilization and disinfection of the air, and it is cheap. In 2003, the main sterilization and disinfectant used in the prevention of SARS in my country was peracetic acid. However, the peracetic acid solution is unstable, so it should be stored in a ventilated and cool place, and its effective concentration should be measured before use; distilled water, deionized water or purified water is used to prepare the diluent, and the diluent should not be stored at room temperature for more than 48 hours. Peracetic acid is highly corrosive to metals, and will decompose violently when mixed with alkalis or organic substances, or even explode. High-concentration liquid medicine is highly corrosive and irritating, and its smell is unacceptable. The most commonly used alcohol disinfectants are ethanol and isopropanol, which can coagulate proteins and cause the death of microorganisms. They are medium-efficiency disinfectants that can kill bacterial propagules and destroy most lipophilic viruses, such as herpes simplex virus and hepatitis B. viruses, human immunodeficiency virus, etc. However, ethanol sterilization has certain requirements on the concentration, and its effective volume fraction should be 65% to 75%. Water is very necessary for the bactericidal effect of ethanol, so ethanol needs to be diluted when used for disinfection, but when the concentration is lower than 30%, the bactericidal effect is very small, and the bactericidal effect will be reduced if the concentration is too strong or too weak. 75% of the unilateral ethanol disinfection preparation is non-toxic to the human body, but due to the different physiques of people, some people are allergic to ethanol, which can cause rash and erythema after contact. Alcohol disinfection preparations are often used, and the skin will be degreased, dry and rough. The bactericidal effect of isopropanol is stronger than that of ethanol, but it is a mildly toxic substance. When it exceeds a certain concentration, it has a strong stimulating effect on the respiratory mucosa and conjunctiva, and can cause cell tissue necrosis. Isopropanol solution has a strong fat-soluble property, and repeated contact with the skin can dry and degrease the skin.
由此可见以上常用消毒剂虽然具有很好的消毒抗菌效果,但用于消毒湿巾均存在明显的缺点,即气味大刺激性强,反复接触皮肤很容易引起不适甚至过敏,因此发明一种安全高效的抗菌湿巾成为市场关注的热点。It can be seen that although the above commonly used disinfectants have good disinfection and antibacterial effects, they all have obvious disadvantages when used in disinfection wet wipes, that is, the smell is strong and irritating, and repeated contact with the skin is easy to cause discomfort or even allergies. Therefore, a safe disinfectant is invented. Efficient antibacterial wet wipes have become a hot spot in the market.
发明内容Contents of the invention
本发明的一个目的在于提供一种安全高效的抗菌湿巾。该湿巾以安全高效的壳聚糖衍生物为抗菌剂、以灭菌无纺布微载体制备而成,该湿巾能全面有效杀灭皮肤表面细菌、对皮肤无毒无刺激,使用后皮肤不干燥,使用方便,便于携带。An object of the present invention is to provide a safe and efficient antibacterial wet wipe. The wet wipes are prepared with safe and efficient chitosan derivatives as antibacterial agents and sterilized non-woven microcarriers. The wet wipes can comprehensively and effectively kill bacteria on the skin surface, and are non-toxic and non-irritating to the skin. Non-drying, easy to use and easy to carry.
本发明的另一个目的在于提供一种安全高效的抗菌湿巾的制备方法。抗菌湿巾的具体制造方法是,将壳聚糖衍生物按相应比例配溶解到去离子水中制成抗菌液,再将无纺布载体浸入,吸足所配制的该抗菌液后密封包装即可。Another object of the present invention is to provide a safe and efficient preparation method of antibacterial wet wipes. The specific manufacturing method of antibacterial wipes is to dissolve chitosan derivatives in corresponding proportions into deionized water to make antibacterial liquid, then immerse the non-woven fabric carrier, absorb enough of the prepared antibacterial liquid, and then seal the package. .
本发明所述安全高效的抗菌湿巾由于采用了具有良好生物相容性、安全无毒无刺激、广谱抗菌性能的壳聚糖衍生物作为抗菌剂,可用于手、医疗器械、家庭日用品等物品表面的抗菌消毒,可有效杀灭常见致病细菌、病毒等有害微生物,且绿色环保、安全无毒无皮肤刺激性、无腐蚀,便于携带和使用。The safe and efficient antibacterial wet wipes of the present invention can be used for hands, medical equipment, household daily necessities, etc. due to the use of chitosan derivatives with good biocompatibility, safety, non-toxicity, non-irritation, and broad-spectrum antibacterial properties as antibacterial agents. The antibacterial disinfection of the surface of the article can effectively kill common pathogenic bacteria, viruses and other harmful microorganisms, and it is green, safe, non-toxic, non-skin irritating, non-corrosive, and easy to carry and use.
为达到上述目的,本发明采用下述技术方案:To achieve the above object, the present invention adopts the following technical solutions:
一种安全高效的抗菌湿巾,所述抗菌湿巾由灭菌无纺布和负载于灭菌无纺布上的壳聚糖衍生物基抗菌液体组成,所述抗菌液体的负载量为50-500wt%;A safe and efficient antibacterial wet wipe, the antibacterial wet wipe is composed of a sterilized non-woven fabric and a chitosan derivative-based antibacterial liquid loaded on the sterilized non-woven fabric, and the load of the antibacterial liquid is 50- 500wt%;
所述抗菌液体包括如下重量份数的原料,以100重量份计:Described antibacterial liquid comprises the raw material of following parts by weight, in 100 parts by weight:
壳聚糖衍生物 0.05-5份,Chitosan derivative 0.05-5 parts,
表面活性剂 0.5-5份,Surfactant 0.5-5 parts,
去离子水 余量。Deionized water balance.
进一步地,所述壳聚糖衍生物为式(1)和/或式(2)所示物质:Further, the chitosan derivative is a substance shown in formula (1) and/or formula (2):
式(1)中,x、y、n为自然数,0<x≦107,0<y≦107,102≦n≦107;In formula (1), x, y, n are natural numbers, 0<x≦10 7 , 0<y≦10 7 , 10 2 ≦n≦10 7 ;
式(2)中,x、y、n为自然数,0<x≤5000,0<y≤5000,10≤n≤5000。In formula (2), x, y, and n are natural numbers, 0<x≤5000, 0<y≤5000, 10≤n≤5000.
式(1)和式(2)所示的物质,是在壳聚糖或羧甲基壳聚糖的基础上进行双功能基团改性得到的壳聚糖衍生物。该两种物质是本申请人首次合成的,将其作为活性物质用于消毒液中,与现有的壳聚糖类消毒液相比,具有抗菌力强和生物安全性高的优势,在溶解和抗菌方面有了相当大的提高和改进。本申请人发现,采用该两种物质作为抗菌湿巾中的活性物质,具有安全性高、无刺激、杀菌快速高效的特点。The substances represented by formula (1) and formula (2) are chitosan derivatives obtained by modifying bifunctional groups on the basis of chitosan or carboxymethyl chitosan. These two substances were synthesized by the applicant for the first time, and they are used as active substances in disinfectants. Compared with existing chitosan disinfectants, they have the advantages of strong antibacterial power and high biological safety. And antibacterial aspect has had considerable improvement and improvement. The applicant found that using these two substances as active substances in antibacterial wet wipes has the characteristics of high safety, no stimulation, and rapid and efficient sterilization.
优选地,本申请人首次合成的式(1)所述物质的制备方法如下:Preferably, the preparation method of the substance described in formula (1) synthesized by the applicant for the first time is as follows:
1)将壳聚糖溶解到水或稀酸溶液中,经水浴加热并搅拌,充分溶解形成壳聚糖的水或稀酸溶液;1) dissolving chitosan in water or dilute acid solution, heating and stirring in a water bath, fully dissolving water or dilute acid solution to form chitosan;
2)用碱溶液调节溶液PH至5~7之间;2) Adjust the pH of the solution to between 5 and 7 with an alkaline solution;
3)向壳聚糖的水或稀酸溶液中缓慢添加胍基化试剂三氧化硫脲,添加完毕后恒温保持搅拌10分钟~60分钟;3) Slowly add the guanidinating reagent thiourea trioxide to the water or dilute acid solution of chitosan, and keep stirring at constant temperature for 10 minutes to 60 minutes after the addition is completed;
4)将精氨酸活化溶液加入上述反应液,在适当的温度下反应6~48小时;4) adding the arginine activation solution to the above reaction solution, and reacting at an appropriate temperature for 6 to 48 hours;
5)向反应液中加入与精氨酸等摩尔当量的盐酸羟胺终止反应;5) Adding hydroxylamine hydrochloride equivalent to arginine in the reaction solution to terminate the reaction;
6)反应液过滤后用去离子水透析,随后进行冷冻干燥处理,即得到产品式(1)所述物质。6) The reaction solution is filtered and then dialyzed with deionized water, followed by freeze-drying to obtain the substance described in the product formula (1).
优选地,本申请人首次合成的式(2)所述物质的制备方法如下:Preferably, the preparation method of the substance described in formula (2) synthesized by the applicant for the first time is as follows:
1)将羧甲基壳聚糖加入到去离子水,室温搅拌均匀,形成羧甲基壳聚糖水溶液,备用;1) Add carboxymethyl chitosan to deionized water, stir evenly at room temperature to form carboxymethyl chitosan aqueous solution, set aside;
2)称取2,3-环氧丙基三甲基氯化铵,溶于去离子水中混匀备用;2) Weigh 2,3-epoxypropyltrimethylammonium chloride, dissolve in deionized water and mix for subsequent use;
3)在加热搅拌条件下,将2,3-环氧丙基三甲基氯化铵溶液分批加入羧甲基壳聚糖溶液中,在2~8小时内加完,然后恒温搅拌不超过12小时;3) Under heating and stirring conditions, add 2,3-epoxypropyltrimethylammonium chloride solution to carboxymethyl chitosan solution in batches, add within 2 to 8 hours, and then stir at constant temperature for no more than 12 hours;
4)反应结束后,待反应产物恢复到室温,用缓冲溶液调节使溶液pH值为5.0~7.5,盐浓度为0.01~0.5M,得到溶液S1;4) After the reaction is finished, wait for the reaction product to return to room temperature, adjust the pH value of the solution with a buffer solution to 5.0-7.5, and the salt concentration is 0.01-0.5M to obtain a solution S1;
5)称取N-羟基琥珀酰亚胺和1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐,溶解于缓冲溶液,得到溶液S2;5) Weighing N-hydroxysuccinimide and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and dissolving them in a buffer solution to obtain a solution S2;
6)称取精氨酸或精氨酸寡聚物加入到溶液S2进行活化,20~50℃搅拌1~5h,得到溶液S3;6) Weigh arginine or arginine oligomers into solution S2 for activation, and stir at 20-50°C for 1-5 hours to obtain solution S3;
7)将S3溶液分批加入到溶液S1中,在加热搅拌条件下反应6~48小时,得到溶液S4;7) adding the S3 solution to the solution S1 in batches, and reacting for 6 to 48 hours under the condition of heating and stirring to obtain the solution S4;
8)反应结束后,将与精氨酸或者精氨酸寡聚物等摩尔当量的盐酸羟胺加入溶液S4,以终止反应;8) After the reaction is over, add hydroxylamine hydrochloride equivalent to the molar equivalent of arginine or arginine oligomers to the solution S4 to terminate the reaction;
9)将反应产物过滤除去不溶物,在去离子水中进行透析,透析袋截留分子量<10000Da,随后进行冷冻干燥处理,即得到固体产物式(2)所述物质。9) Filter the reaction product to remove insoluble matter, perform dialysis in deionized water, the molecular weight cut-off of the dialysis bag is <10000Da, and then perform freeze-drying treatment to obtain the solid product described in formula (2).
进一步地,所述壳聚糖衍生物还包括如下所示的物质中的一种或多种:Further, the chitosan derivative also includes one or more of the following substances:
式(3)中,x、y、n为自然数,0<x≤5000,0<y≤5000,1≤n≤30;In formula (3), x, y, n are natural numbers, 0<x≤5000, 0<y≤5000, 1≤n≤30;
式(4)中,X-为Cl-或HSO3 -,x、n为自然数,0<x≦107,102≦n≦107;In formula (4), X - is Cl - or HSO 3 - , x and n are natural numbers, 0<x≦10 7 , 10 2 ≦n≦10 7 ;
式(5)中,x、n为自然数,0<x≦107,10≦n≦107;In formula (5), x and n are natural numbers, 0<x≦10 7 , 10≦n≦10 7 ;
式(6)中,x、n为自然数,0<x≦107,102≦n≦107;In formula (6), x and n are natural numbers, 0<x≦10 7 , 10 2 ≦n≦10 7 ;
式(7)中,x、n为自然数,0<x≦107,102≦n≦107;In formula (7), x and n are natural numbers, 0<x≦10 7 , 10 2 ≦n≦10 7 ;
式(8)中,X-为F-、Cl-、Br-、HSO4 -或RCOO-,x、n为自然数,0<x≦107,102≦n≦107;In formula (8), X - is F - , Cl - , Br - , HSO 4 - or RCOO - , x and n are natural numbers, 0<x≦10 7 , 10 2 ≦n≦10 7 ;
式(9)中,x、n为自然数,0<x≦107,102≦n≦107;In formula (9), x and n are natural numbers, 0<x≦10 7 , 10 2 ≦n≦10 7 ;
式(10)中,x、n为自然数,0<x≦107,102≦n≦107;In formula (10), x and n are natural numbers, 0<x≦10 7 , 10 2 ≦n≦10 7 ;
式(11)中,x、y、n为自然数,0<x≦107,0<y≦107,102≦n≦107;In formula (11), x, y, n are natural numbers, 0<x≦10 7 , 0<y≦10 7 , 10 2 ≦n≦10 7 ;
式(12)中,X-为F-、Cl-、Br-、HSO4 -或RCOO-,y、n为自然数,0<y≦107,102≦n≦107;In formula (12), X - is F - , Cl - , Br - , HSO 4 - or RCOO - , y and n are natural numbers, 0<y≦10 7 , 10 2 ≦n≦10 7 ;
式(13)中,X-为F-、Cl-、Br-、HSO4 -或RCOO-,y、n为自然数,0<y≦107,102≦n≦107。In formula (13), X - is F - , Cl - , Br - , HSO 4 - or RCOO - , y and n are natural numbers, 0<y≦10 7 , 10 2 ≦n≦10 7 .
优选地,式(3)所述物质也是本申请人首次合成的,该物质的制备方法如下:Preferably, the substance described in formula (3) is also synthesized by the applicant for the first time, and the preparation method of the substance is as follows:
1)称取羧甲基壳聚糖加入去离子水,室温搅拌均匀,形成羧甲基壳聚糖水溶液,备用;1) Weigh carboxymethyl chitosan and add deionized water, stir evenly at room temperature to form carboxymethyl chitosan aqueous solution, set aside;
2)称取N-羟基琥珀酰亚胺和1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐,溶解于缓冲溶液,得到溶液S1;2) Weighing N-hydroxysuccinimide and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, and dissolving them in a buffer solution to obtain solution S1;
3)称取精氨酸或精氨酸寡聚物加入到溶液S1进行活化,室温搅拌0.5~4h,得到溶液S2;3) Weigh arginine or arginine oligomers and add them to solution S1 for activation, and stir at room temperature for 0.5-4 hours to obtain solution S2;
4)将溶液S2分批加入到羧甲基壳聚糖水溶液中,在加热搅拌条件下反应6~48小时,得到溶液S3;4) adding solution S2 to carboxymethyl chitosan aqueous solution in batches, reacting under heating and stirring conditions for 6-48 hours to obtain solution S3;
5)反应结束后,将与精氨酸或精氨酸寡聚物等摩尔当量的盐酸羟胺加入溶液S3,以终止反应;5) After the reaction is over, add hydroxylamine hydrochloride in equimolar equivalents to arginine or arginine oligomers into solution S3 to terminate the reaction;
6)将反应产物在去离子水中进行透析,透析袋截留分子量<5000Da,随后进行冷冻干燥处理,即得到固体产物式(3)所述物质。6) The reaction product is dialyzed in deionized water, the molecular weight cut-off of the dialysis bag is <5000Da, and then freeze-dried to obtain the solid product described in formula (3).
进一步地,式(11)所述物质也是本申请人首次合成的,该物质的制备方法如下:Further, the substance described in formula (11) is also synthesized by the applicant for the first time, and the preparation method of the substance is as follows:
1)将羧甲基壳聚糖溶解到去离子水中,经水浴加热并搅拌,充分溶解形成羧甲基壳聚糖的水溶液;1) carboxymethyl chitosan is dissolved in deionized water, heated and stirred in a water bath, fully dissolved to form an aqueous solution of carboxymethyl chitosan;
2)向羧甲基壳聚糖的水溶液中缓慢添加胍基化试剂三氧化硫脲,添加完毕后恒温保持搅拌10分钟~60分钟;2) Slowly add the guanidinating reagent thiourea trioxide to the aqueous solution of carboxymethyl chitosan, and keep stirring at constant temperature for 10 minutes to 60 minutes after the addition is completed;
3)将精氨酸活化溶液加入上述反应液,在适当的温度下反应6~48小时;3) adding the arginine activation solution to the above reaction solution, and reacting at an appropriate temperature for 6 to 48 hours;
4)向反应液中加入与精氨酸等摩尔当量的盐酸羟胺终止反应;4) Adding hydroxylamine hydrochloride equivalent to arginine in the reaction solution to terminate the reaction;
5)反应液过滤后用去离子水透析,随后进行冷冻干燥处理,即得到产品式(11)所述物质。5) The reaction solution is filtered and dialyzed with deionized water, followed by freeze-drying to obtain the substance described in the product formula (11).
优选地,所述表面活性剂为吐温系列产品、三乙醇胺、乙氧基化烷基硫酸钠、月桂醇聚醚硫酸酯钠、硬脂酸及其衍生物中的一种或多种。Preferably, the surfactant is one or more of Tween series products, triethanolamine, sodium ethoxylated alkyl sulfate, sodium lauryl ether sulfate, stearic acid and its derivatives.
所述吐温系列产品是指市售能够获得的吐温系列产品,例如吐温20、吐温60、吐温80等。The Tween series products refer to commercially available Tween series products, such as Tween 20, Tween 60, Tween 80 and the like.
本发明还公开了如上所述的安全高效抗菌湿巾的制备方法:先0.05-5重量份的壳聚糖衍生物和0.5-5重量份数的表面活性剂加入到剩余重量份数的去离子水中,充分搅拌使壳聚糖衍生物完全溶解变成澄清透明溶液,即可得到壳聚糖衍生物基抗菌液体;然后将灭菌无纺布置于上述抗菌液体中室温下浸泡5-10分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾。The invention also discloses the preparation method of the safe and high-efficiency antibacterial wet wipes as described above: first, 0.05-5 parts by weight of chitosan derivatives and 0.5-5 parts by weight of surfactant are added to the remaining parts by weight of deionized In water, fully stir to dissolve the chitosan derivative completely and turn it into a clear and transparent solution to obtain a chitosan derivative-based antibacterial liquid; then place the sterilized non-woven fabric in the above antibacterial liquid and soak it for 5-10 minutes at room temperature The safe and efficient antibacterial wet wipes can be obtained after taking out and draining the sealed package.
现有技术中,湿巾主要分两类:一类是本身已经被消毒,但对其他物品没有抗菌保护作用,里面含有护肤的成分,只能做皮肤湿润保养的;另一类是不仅本身被消毒,而且对别的物品也可起到消毒作用的消毒湿巾,可以用做皮肤和日常生活用品的消毒或杀菌,但所含抗菌成分多为过氧化物或醇类,存在气味大刺激性强的缺点,反复接触皮肤很容易引起不适甚至过敏。In the prior art, wet wipes are mainly divided into two categories: one type has been sterilized itself, but has no antibacterial protection effect on other items, and contains skin care ingredients, which can only be used for skin moisturizing and maintenance; the other type is not only used by itself Disinfection, and disinfectant wipes that can also disinfect other items can be used to disinfect or sterilize skin and daily necessities, but the antibacterial ingredients contained are mostly peroxides or alcohols, which have a strong odor Strong disadvantages, repeated skin contact can easily cause discomfort or even allergies.
针对现有技术的不足,本申请人经过大量的实验验证,采用壳聚糖衍生物作为抗菌剂,适当添加表面活性剂,无纺布作为载体,控制抗菌液体的负载量为50-500wt%,制备出一种安全高效抗菌湿巾。同时通过大量的实验验证,将抗菌液体的组成限定为100重量份中壳聚糖衍生物0.05-5份,表面活性剂0.5-5份,水余量时,湿巾中的有效抗菌成分能发挥出最大的功效。Aiming at the deficiencies in the prior art, the applicant has verified through a large number of experiments that chitosan derivatives are used as antibacterial agents, surfactants are added appropriately, non-woven fabrics are used as carriers, and the load of antibacterial liquid is controlled to be 50-500wt%. A safe and highly effective antibacterial wet wipe was prepared. At the same time, through a large number of experimental verifications, the composition of the antibacterial liquid is limited to 0.05-5 parts of chitosan derivatives in 100 parts by weight, and 0.5-5 parts of surfactants. Get the most out of it.
本发明的湿巾具有高效抗菌作用,通过擦拭即可快速杀死人体或物体表面的细菌,并且对人体安全无毒、无害、无刺激,绿色环保,携带方便,适用于医院、宾馆、饭店、家庭等场合以及外出人员、财会人员使用。The wet tissue of the present invention has high-efficiency antibacterial effect, can quickly kill bacteria on the surface of the human body or objects by wiping, is safe, non-toxic, harmless, and non-irritating to the human body, is environmentally friendly, and is easy to carry, and is suitable for hospitals, hotels, and restaurants , families and other occasions, as well as people who go out and accountants.
需要注意的是:上述式(1)-(13)的分子结构式中,各个重复单元的排列顺序并非是完全按照结构式中所标注的顺序,而是采取无规则的排列方式在高分子链中进行排列组合的。It should be noted that in the above molecular structural formulas (1)-(13), the arrangement order of each repeating unit is not completely in accordance with the order marked in the structural formula, but is carried out in the polymer chain in an irregular arrangement. arranged in combination.
另外注意的是,如果没有特别说明,本发明所记载的任何范围包括端值以及端值之间的任何数值以及以端值或者端值之间的任意数值所构成的任意子范围。It should also be noted that if there is no special description, any range described in the present invention includes the end value and any value between the end values and any sub-range formed by the end value or any value between the end values.
本发明的有益效果如下:The beneficial effects of the present invention are as follows:
本发明所涉及的安全高效的抗菌湿巾,专门针对现有技术的不足之处而设计开发,选用绿色环保的壳聚糖衍生物这一生物天然高分子改性抗菌材料作为抗菌剂,安全无毒、无刺激,抗菌力强且长效抗菌;无需用水,节约水资源。The safe and efficient antibacterial wet wipes involved in the present invention are specially designed and developed for the deficiencies of the prior art. The green and environmentally friendly chitosan derivatives, a bionatural polymer modified antibacterial material, are selected as antibacterial agents, which are safe and non-toxic. Toxic, non-irritating, strong antibacterial and long-lasting antibacterial; no need for water, saving water resources.
具体实施方式detailed description
为了更清楚地说明本发明,下面结合优选实施例对本发明做进一步的说明。本领域技术人员应当理解,下面所具体描述的内容是说明性的而非限制性的,不应以此限制本发明的保护范围。In order to illustrate the present invention more clearly, the present invention will be further described below in conjunction with preferred embodiments. Those skilled in the art should understand that the content specifically described below is illustrative rather than restrictive, and should not limit the protection scope of the present invention.
实施例1Example 1
制备合成本发明式(1)所述物质:Prepare and synthesize the material described in formula (1) of the present invention:
称取0.1克壳聚糖加入到100毫升去离子水中,室温下机械搅拌半小时,以便壳聚糖溶解完全,从而得到质量体积百分比浓度为0.1%的均匀溶液;室温下,向壳聚糖水溶液体系中缓慢加入三氧化硫脲,三氧化硫脲与壳聚糖的摩尔比为10:1,投料用时30分钟,室温下反应保持60分钟;然后将在冰水混合浴中活化3小时的精氨酸、N-羟基琥珀酰亚胺(NHS)和1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC·HCl)的混合溶液(溶剂为30mmol/L的2-(N-吗啉代)乙烷磺酸(MES)的缓冲溶液)20ml加入上述反应液中,于室温下持续搅拌反应48小时,其中壳聚糖、精氨酸、NHS、EDC的摩尔比为50:1:5:5;然后将反应液装入透析袋,将透析袋两端扎紧放入去离子水中透析处理,每隔五小时换水一次,换水八次后将透析液放入-86℃冰箱冷冻一小时后,放入冻干机直至冻干为止即可得式(1)所述物质双功能基团改性的壳聚糖衍生物。Take by weighing 0.1 gram of chitosan and join in 100 milliliters of deionized water, mechanically stir at room temperature for half an hour, so that chitosan dissolves completely, thereby obtain the homogeneous solution that mass volume percent concentration is 0.1%; Slowly add thiourea trioxide into the system, the molar ratio of thiourea trioxide and chitosan is 10:1, the feeding time is 30 minutes, and the reaction at room temperature is kept for 60 minutes; A mixed solution of amino acid, N-hydroxysuccinimide (NHS) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl) (solvent: 30mmol/ L of 2-(N-morpholino)ethanesulfonic acid (MES) buffer solution) 20ml was added to the above-mentioned reaction solution, and the stirring reaction was continued at room temperature for 48 hours, wherein chitosan, arginine, NHS, EDC The molar ratio of the solution is 50:1:5:5; then the reaction solution is put into a dialysis bag, the two ends of the dialysis bag are tied tightly and put into deionized water for dialysis treatment, and the water is changed every five hours, and the water is changed eight times. After the dialysate is put into a refrigerator at -86° C. for one hour, put into a lyophilizer until it is lyophilized to obtain a chitosan derivative modified by a bifunctional group of the substance described in formula (1).
制备抗菌湿巾:To prepare antibacterial wipes:
称取8克上述制备得到的式(1)所述物质和吐温20表面活性剂1克,加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体a;然后将灭菌无纺布置于上述抗菌液体a中室温下浸泡5分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾A。Weigh 8 grams of the substance described in formula (1) prepared above and 1 gram of Tween 20 surfactant, add it to 100 milliliters of sterilized deionized water, stir fully to make it completely dissolve and become a clear and transparent solution, to obtain Antibacterial liquid a; then soak the sterilized non-woven cloth in the above antibacterial liquid a at room temperature for 5 minutes, take out, drain and seal the package to obtain the safe and efficient antibacterial wet wipe A.
实施例2Example 2
制备合成本发明式(2)所述物质:Prepare and synthesize the material described in formula (2) of the present invention:
称取0.1g羧甲基壳聚糖(数均分子量为2x105Da,羧甲基取代度为100%,脱乙酰度为100%)加入100mL去离子水,室温下机械搅拌均匀,使羧甲基壳聚糖完全溶解,从而得到质量体积百分比浓度为0.1%的溶液;称取2,3-环氧丙基三甲基氯化铵,溶于50mL去离子水,室温下机械搅拌均匀;在40℃搅拌条件下,将2,3-环氧丙基三甲基氯化铵溶液分3次缓慢加入羧甲基壳聚糖溶液中,投料用时4小时,然后恒温搅拌4小时;反应结束后,待反应产物恢复到室温,用1M pH 5.0MES/HCl缓冲溶液调节使溶液pH值为5.0,盐浓度为0.01M,得到溶液S1;称取NHS和EDC(摩尔比为1:10),溶解于30mL 0.01M pH 5.0MES/HCl缓冲溶液,得到溶液S2;称取精氨酸加入到溶液S2进行活化,室温搅拌1h;将精氨酸活化溶液分3次倒入到溶液S1,在20℃搅拌条件下反应48小时;反应结束后,将与精氨酸等摩尔比的盐酸羟胺加入反应溶液,以终止反应;反应产物过滤除去不溶物,在2L去离子水中进行透析,透析袋截留分子量1000Da,每2小时换一次水,换10次水后,将透析液倒入1L圆底烧瓶,在液氮中冷冻,并不断旋转烧瓶使透析液在瓶底形成薄层,随后进行冻干处理,即得到式(2)所述物质固体双改性羧甲基壳聚糖衍生物。该反应中,羧甲基壳聚糖与2,3-环氧丙基三甲基氯化铵质量比为1:0.1,羧甲基壳聚糖、精氨酸与EDC摩尔比为1:1:0.5。Weigh 0.1g carboxymethyl chitosan (the number average molecular weight is 2×10 5 Da, carboxymethyl substitution degree is 100%, deacetylation degree is 100%), add 100mL deionized water, stir mechanically at room temperature, make carboxymethyl chitosan Base chitosan is completely dissolved, thereby obtaining the solution that the mass volume percent concentration is 0.1%; Weigh 2,3-epoxypropyltrimethylammonium chloride, be dissolved in 50mL deionized water, mechanically stir at room temperature; Under the condition of stirring at 40°C, slowly add the 2,3-epoxypropyltrimethylammonium chloride solution into the carboxymethyl chitosan solution in 3 times, and the feeding time is 4 hours, and then stirred at constant temperature for 4 hours; , when the reaction product returned to room temperature, adjusted with 1M pH 5.0 MES/HCl buffer solution to make the solution pH 5.0, salt concentration 0.01M, to obtain solution S1; weigh NHS and EDC (molar ratio 1:10), dissolve In 30mL 0.01M pH 5.0 MES/HCl buffer solution to obtain solution S2; weigh arginine and add it to solution S2 for activation, stir at room temperature for 1h; pour arginine activation solution into solution S1 in 3 times, React under stirring conditions for 48 hours; after the reaction, add hydroxylamine hydrochloride in an equimolar ratio to arginine to the reaction solution to terminate the reaction; filter the reaction product to remove insoluble matter, and perform dialysis in 2L deionized water, the molecular weight cut-off of the dialysis bag is 1000Da , change the water every 2 hours, after changing the water 10 times, pour the dialysate into a 1L round bottom flask, freeze in liquid nitrogen, and rotate the flask continuously to make the dialysate form a thin layer at the bottom of the bottle, and then freeze-dry. Promptly obtain the material solid double-modified carboxymethyl chitosan derivative described in formula (2). In this reaction, the mass ratio of carboxymethyl chitosan to 2,3-epoxypropyltrimethylammonium chloride is 1:0.1, and the molar ratio of carboxymethyl chitosan, arginine to EDC is 1:1. : 0.5.
制备抗菌湿巾:To prepare antibacterial wipes:
称取10克上述制备得到的式(2)所述物质和三乙醇胺表面活性剂5克,加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体b;然后将灭菌无纺布置于上述抗菌液体b中室温下浸泡10分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾B。Take by weighing 10 grams of the substance described in formula (2) prepared above and 5 grams of triethanolamine surfactant, add to 100 milliliters of sterilized deionized water, fully stir to make it dissolve completely and become a clear and transparent solution, to obtain antibacterial Liquid b; then soak the sterilized non-woven cloth in the above antibacterial liquid b at room temperature for 10 minutes, take it out, drain and seal the package to obtain the safe and efficient antibacterial wet wipe B.
实施例3Example 3
制备合成本发明式(3)所述物质:Prepare and synthesize the material described in formula (3) of the present invention:
称取0.35g羧甲基壳聚糖(数均分子量为2x105Da,羧甲基取代度为100%,脱乙酰度为95%)加入35mL去离子水,室温下机械搅拌均匀,使羧甲基壳聚糖完全溶解,从而得到质量体积百分比浓度为1%的溶液;称取NHS和EDC(摩尔比为1:1),溶解于15mL 0.01M pH5.0MES/HCl缓冲溶液,得到催化剂溶液;称取精氨酸加入到催化剂溶液进行活化,室温搅拌1小时;将精氨酸活化溶液分3次倒入到羧甲基壳聚糖溶液,在45℃搅拌条件下反应24小时;反应结束后,将与精氨酸等摩尔比的盐酸羟胺加入反应溶液,以终止反应;反应产物在1L去离子水中进行透析,透析袋截留分子量5000Da,每2小时换一次水;换8次水后,将透析液倒入250mL圆底烧瓶,在液氮中冷冻,并不断旋转烧瓶使透析液在瓶壁上形成薄层,随后进行冻干处理,即得到式(3)所述物质固体(寡聚)精氨酸改性羧甲基壳聚糖衍生物。该反应中,羧甲基壳聚糖、精氨酸与EDC摩尔比为1:0.05:0.25。Weigh 0.35g of carboxymethyl chitosan (the number average molecular weight is 2×10 5 Da, the degree of carboxymethyl substitution is 100%, the degree of deacetylation is 95%), add 35mL of deionized water, and stir mechanically at room temperature to make the carboxymethyl chitosan The base chitosan was completely dissolved, thereby obtaining a solution with a mass volume percentage concentration of 1%; Weighing NHS and EDC (the molar ratio was 1:1), dissolved in 15mL 0.01M pH5.0MES/HCl buffer solution, to obtain a catalyst solution; Weigh arginine and add it to the catalyst solution for activation, stir at room temperature for 1 hour; pour the arginine activation solution into the carboxymethyl chitosan solution in 3 times, and react for 24 hours under stirring at 45°C; after the reaction , the hydroxylamine hydrochloride with the equimolar ratio of arginine is added to the reaction solution to terminate the reaction; the reaction product is dialyzed in 1L deionized water, the molecular weight cut-off of the dialysis bag is 5000Da, and the water is changed every 2 hours; after changing the water 8 times, the The dialysate is poured into a 250mL round bottom flask, frozen in liquid nitrogen, and the flask is continuously rotated so that the dialysate forms a thin layer on the wall of the bottle, and then freeze-dried to obtain the solid (oligomeric) substance described in formula (3). Arginine modified carboxymethyl chitosan derivatives. In this reaction, the molar ratio of carboxymethyl chitosan, arginine and EDC is 1:0.05:0.25.
制备抗菌湿巾:To prepare antibacterial wipes:
分别称取上述制备得到的式(1)所述物质5克、式(3)所述物质1克和吐温80表面活性剂2克,加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体c;然后将灭菌无纺布置于上述抗菌液体c中室温下浸泡8分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾C。Take by weighing 5 grams of the substance described in formula (1) prepared above, 1 gram of the substance described in formula (3) and 2 grams of Tween 80 surfactant respectively, join in 100 milliliters of sterilized deionized water, fully stir to make it Completely dissolve into a clear and transparent solution to obtain the antibacterial liquid c; then soak the sterilized non-woven fabric in the above antibacterial liquid c at room temperature for 8 minutes, take it out, drain and seal the package to obtain the safe and efficient antibacterial wet wipe c.
实施例4Example 4
制备抗菌湿巾:To prepare antibacterial wipes:
分别称取按照实施例1的制备方法得到的式(1)所述物质2克、式(10)所述物质3克和表面活性剂乙氧基化烷基硫酸钠3克,加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体d;然后将灭菌无纺布置于上述抗菌液体d中室温下浸泡6分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾D。Take by weighing respectively 2 grams of substances described in formula (1), 3 grams of substances described in formula (10) and 3 grams of surfactant ethoxylated alkylsulfate sodium that are obtained according to the preparation method of Example 1, add to 100 milliliters In sterilized deionized water, stir fully to make it completely dissolve and become a clear and transparent solution to obtain the antibacterial liquid d; then put the sterilized non-woven fabric in the above antibacterial liquid d and soak it for 6 minutes at room temperature, take it out, drain and seal the package. The safe and efficient antibacterial wet wipe D can be obtained.
实施例5Example 5
制备抗菌湿巾:To prepare antibacterial wipes:
分别称取按照实施例2的制备方法得到的式(2)所述物质0.5g、式(4)所述物质2克和表面活性剂月桂醇聚醚硫酸酯钠2.5克,加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体e;然后将灭菌无纺布置于上述抗菌液体e中室温下浸泡7分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾E。Weigh respectively 0.5 g of the substance described in formula (2) obtained according to the preparation method of Example 2, 2 grams of the substance described in formula (4) and 2.5 grams of surfactant sodium lauryl ether sulfate, add to 100 milliliters Bacterial deionized water, fully stirred to make it completely dissolve into a clear and transparent solution, and then the antibacterial liquid e can be obtained; then the sterilized non-woven fabric is soaked in the above antibacterial liquid e for 7 minutes at room temperature, taken out, drained and sealed. Obtain the safe and efficient antibacterial wet tissue E.
实施例6Example 6
制备抗菌湿巾:To prepare antibacterial wipes:
分别称取按照实施例2的制备方法得到的式(2)所述物质、式(7)所述物质各1克和表面活性剂硬脂酸3克,加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体f;然后将灭菌无纺布置于上述抗菌液体f中室温下浸泡9分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾F。Take by weighing respectively the material described in formula (2) that obtains according to the preparation method of embodiment 2, each 1 gram of material described in formula (7) and surfactant stearic acid 3 grams, join in 100 milliliters of sterilized deionized water, Fully stir to make it completely dissolve into a clear and transparent solution to obtain the antibacterial liquid f; then soak the sterilized non-woven fabric in the above antibacterial liquid f at room temperature for 9 minutes, take it out, drain and seal the package to obtain the safe and efficient The antibacterial wipes F.
实施例7Example 7
制备抗菌湿巾:To prepare antibacterial wipes:
分别称取按照实施例1的制备方法得到的式(1)所述物质和实施例2制备得到的式(2)所述物质各2克以及表面活性剂三乙醇胺4克,加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体g;然后将灭菌无纺布置于上述抗菌液体g中室温下浸泡5分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾G。Weigh respectively 2 grams of the substance described in formula (1) obtained according to the preparation method of Example 1 and the substance described in formula (2) prepared in Example 2 and 4 grams of surfactant triethanolamine, add to 100 milliliters Bacterial deionized water, fully stirred to make it completely dissolve into a clear and transparent solution, and then the antibacterial liquid g can be obtained; then sterilized non-woven fabrics are soaked in the above antibacterial liquid g for 5 minutes at room temperature, taken out, drained and sealed. The safe and efficient antibacterial wet wipe G is obtained.
实施例8Example 8
制备抗菌湿巾:To prepare antibacterial wipes:
称取按照实施例1的制备方法得到的式(1)所述物质0.5克,以及表面活性剂三乙醇胺2克加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体h;然后将灭菌无纺布置于上述抗菌液体h中室温下浸泡5分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾H。Weigh 0.5 grams of the substance described in formula (1) obtained according to the preparation method of Example 1, and 2 grams of surfactant triethanolamine are added to 100 milliliters of sterilized deionized water, fully stirred to make it completely dissolve and become a clear and transparent solution , to obtain the antibacterial liquid h; then soak the sterilized non-woven cloth in the above antibacterial liquid h at room temperature for 5 minutes, take out, drain and seal the package to obtain the safe and efficient antibacterial wet wipe H.
实施例9Example 9
制备抗菌湿巾:To prepare antibacterial wipes:
分别称取按照实施例1的制备方法得到的式(1)所述物质0.1克,实施例2的制备方法得到的式(2)所述物质0.1克,以及式(12)所述物质0.1克,以及吐温80表面活性剂0.1克加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体i;然后将灭菌无纺布置于上述抗菌液体i中室温下浸泡5分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾I。Weigh respectively 0.1 gram of the substance described in the formula (1) obtained according to the preparation method of Example 1, 0.1 gram of the substance described in the formula (2) obtained by the preparation method of Example 2, and 0.1 gram of the substance described in the formula (12) , and 0.1 g of Tween 80 surfactant is added to 100 ml of sterilized deionized water, fully stirred to make it completely dissolve into a clear and transparent solution, and then antibacterial liquid i can be obtained; Soak in liquid i at room temperature for 5 minutes, take out, drain and seal the package to obtain the safe and efficient antibacterial wet wipe I.
实施例10Example 10
制备抗菌湿巾:To prepare antibacterial wipes:
分别称取按照实施例2的制备方法得到的式(2)所述物质0.1克,式(13)所述物质0.1克,以及式(6)所述物质0.5g,以及表面活性剂月桂醇聚醚硫酸酯钠1g加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体j;然后将灭菌无纺布置于上述抗菌液体j中室温下浸泡5分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾J。Weigh respectively 0.1 gram of the substance described in formula (2) obtained according to the preparation method of Example 2, 0.1 gram of the substance described in formula (13), and 0.5 g of the substance described in formula (6), and surfactant lauryl alcohol Add 1 g of sodium ether sulfate to 100 ml of sterilized deionized water, stir fully to make it completely dissolve and become a clear and transparent solution, and then get the antibacterial liquid j; then arrange the sterilized nonwoven in the above antibacterial liquid j at room temperature Soak for 5 minutes, take out, drain and seal the package to get the safe and efficient antibacterial wet wipe J.
对比例1Comparative example 1
制备抗菌湿巾:To prepare antibacterial wipes:
称取市售的壳聚糖8g,以及表面活性剂吐温20 1克,加入到100毫升灭菌去离子水中,加入适量酸充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体k;然后将灭菌无纺布置于上述抗菌液体k中室温下浸泡5分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾K。Weigh 8 g of commercially available chitosan and 20 1 g of Tween surfactant, add it to 100 ml of sterilized deionized water, add an appropriate amount of acid and fully stir to make it completely dissolve and become a clear and transparent solution to obtain the antibacterial liquid k; then soak the sterilized non-woven cloth in the above antibacterial liquid k at room temperature for 5 minutes, take it out, drain and seal the package to obtain the safe and efficient antibacterial wet wipe K.
对比例2Comparative example 2
制备抗菌湿巾:To prepare antibacterial wipes:
称取市售的羧甲基壳聚糖8g,以及表面活性剂吐温20 1克,加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体l;然后将灭菌无纺布置于上述抗菌液体l中室温下浸泡5分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾L。Weigh commercially available carboxymethyl chitosan 8g, and surfactant Tween 20 1g, add to 100 milliliters of sterilized deionized water, fully stir to make it dissolve completely and become a clear and transparent solution to obtain the antibacterial liquid 1; then soak the sterilized non-woven fabric in the above-mentioned antibacterial liquid 1 at room temperature for 5 minutes, take it out, drain and seal the package to obtain the safe and efficient antibacterial wet wipe L.
对比例3Comparative example 3
制备抗菌湿巾:To prepare antibacterial wipes:
称取按照实施例1的制备方法得到的式(1)所述物质0.01克,以及表面活性剂吐温20 1克,加入到100毫升灭菌去离子水中,充分搅拌使其完全溶解变成澄清透明溶液,即可得抗菌液体m;然后将灭菌无纺布置于上述抗菌液体m中室温下浸泡5分钟取出沥干密封包装即可得到所述安全高效的抗菌湿巾M。Take by weighing 0.01 gram of the substance described in formula (1) obtained according to the preparation method of Example 1, and 20 1 gram of surfactant Tween, join in 100 milliliters of sterilized deionized water, fully stir to make it dissolve completely and become clear transparent solution to obtain the antibacterial liquid m; then soak the sterilized non-woven cloth in the above antibacterial liquid m at room temperature for 5 minutes, take it out, drain and seal the package to obtain the safe and efficient antibacterial wet wipe M.
本发明实施例1-10以及对比例1-3所制备的抗菌湿巾的抗菌液体负载量均在50-500wt%之间。对抗菌湿巾A-M分别进行了微生物的杀菌效果测试以及毒理学试验,测试结果如下所述。The antibacterial liquid loads of the antibacterial wet wipes prepared in Examples 1-10 and Comparative Examples 1-3 of the present invention are all between 50-500wt%. Antibacterial wet wipes A-M were tested for microbial bactericidal effect and toxicology test respectively, and the test results are as follows.
对微生物的杀菌效果观察如下:The bactericidal effect on microorganisms was observed as follows:
将实施例样品及对比例所制备的抗菌湿巾按照国标GB15979-2002的方法,对皮肤消毒表面的消毒效果进行测试。并将抗菌液体于54℃条件下的恒温烘箱内放置15天后,再制备抗菌湿巾观察杀菌效果的变化。According to the national standard GB15979-2002, the antibacterial wet wipes prepared by the sample of the example and the comparative example were tested for their disinfection effect on the skin disinfection surface. After the antibacterial liquid was placed in a constant temperature oven at 54°C for 15 days, antibacterial wet wipes were prepared to observe the changes in the bactericidal effect.
消毒液A-M的杀菌效果测试列表如下:The bactericidal effect test list of disinfectant A-M is as follows:
表1实施例及对比例消毒液杀菌效果统计表Table 1 embodiment and comparative example disinfectant bactericidal effect statistical table
该杀菌效果测试结果表明:该抗菌湿巾对皮肤表面的常见致病菌具有良好抗菌效果,对比例K中,壳聚糖溶于酸性溶液中具有一定的抗菌性能,但抗菌效果并不好,而对比例L中,羧甲基壳聚糖水溶液在同样的测试浓度下完全没有抗菌性能;对比例M中,由于浓度达不到本发明限定的浓度范围,因此湿巾的抗菌性能很差。另外,将实施例A-J中的抗菌液体在54℃条件下的恒温烘箱内放置15天后,再用相同的方法制备出相同的抗菌湿巾,对其抗大肠杆菌、金黄色葡萄球菌、白色念珠菌以及绿脓杆菌的抗菌性能进行相同的测试,发现其抗菌活性没有明显变化,说明本发明的抗菌湿巾的抗菌活性稳定长效。The bactericidal effect test results show that: the antibacterial wet wipe has a good antibacterial effect on common pathogenic bacteria on the skin surface. In Comparative Example K, chitosan dissolved in an acidic solution has certain antibacterial properties, but the antibacterial effect is not good. And in the comparative example L, the carboxymethyl chitosan aqueous solution has no antibacterial performance at all under the same test concentration; In the comparative example M, because the concentration does not reach the concentration range limited by the present invention, the antibacterial performance of the wet tissue is very poor. In addition, after placing the antibacterial liquid in Examples A-J in a constant temperature oven at 54°C for 15 days, the same method was used to prepare the same antibacterial wet wipes, which were resistant to Escherichia coli, Staphylococcus aureus, and Candida albicans. And the antibacterial performance of Pseudomonas aeruginosa was tested in the same way, and it was found that its antibacterial activity had no obvious change, indicating that the antibacterial activity of the antibacterial wet wipe of the present invention was stable and long-lasting.
毒理学测试如下:Toxicological tests are as follows:
家兔急性皮肤刺激性试验步骤Rabbit acute skin irritation test procedure
试验前约24h,将实验动物背部脊柱两侧毛剪掉,不可损伤表皮,去毛范围左、右各约3cm×3cm。取抗菌液体约0.5mL直接涂在皮肤上,然后用二层纱布(2.5cm×2.5cm)和一层玻璃纸或类似物覆盖,再用无刺激性胶布和绷带加以固定。另一侧皮肤作为对照。采用封闭试验,敷用时间为4h。试验结束后用温水或无刺激性溶剂清除残留受试物。About 24 hours before the test, the hair on both sides of the back and spine of the experimental animals was cut off without damaging the epidermis. Take about 0.5mL of antibacterial liquid and apply it directly on the skin, then cover it with two layers of gauze (2.5cm×2.5cm) and a layer of cellophane or similar, and then fix it with non-irritating adhesive tape and bandage. The skin on the other side served as a control. The closed test was adopted, and the application time was 4 hours. After the test, remove the residual test substance with warm water or non-irritating solvent.
于清除抗菌液体后的1、24、48、72h和7天观察涂抹部位皮肤反应,根据表2进行皮肤反应评分,以受试动物积分的平均值进行综合评价,根据1、24、48、72h和7天各观察时点最高积分均值,根据表3判定皮肤刺激强度。Observe the skin reaction at the application site 1, 24, 48, 72h and 7 days after the antibacterial liquid is removed, score the skin reaction according to Table 2, and conduct a comprehensive evaluation based on the average value of the points of the tested animals. and the highest integral mean value at each observation point in 7 days, determine the skin irritation intensity according to Table 3.
表2皮肤刺激反应评分Table 2 Skin irritation score
表3皮肤刺激强度分级Table 3 Grading of skin irritation intensity
家兔一次眼刺激试验步骤:Rabbit eye irritation test steps:
(1)固定兔子,轻轻拉开兔子右眼眼睛的下眼睑,给予受试样品0.5ml滴入(或放入)结膜囊中,使上、下眼帘被动闭合30s,以防止受试样品丢失,未处理的另一侧眼睛作为自身对照或滴入溶媒。(1) Fix the rabbit, gently pull the lower eyelid of the rabbit's right eye, give 0.5ml of the test sample to drop (or put) into the conjunctival sac, and passively close the upper and lower eyelids for 30 seconds to prevent the test sample from The product was lost, and the untreated other eye was used as its own control or instilled with vehicle.
(2)滴入30s后用生理盐水冲洗。在滴入受试样品后的第1h、24h、48h、72h、4d和7d对眼睛进行检查,如果72h时未出现刺激反应,可终止试验。如果发现累及角膜或有其它眼刺激作用,7d内不恢复者,为确定该损害的可逆性或不可逆性需延长观察时间,一般不超过21d。(2) Rinse with normal saline after dripping for 30 seconds. Check the eyes at 1h, 24h, 48h, 72h, 4d and 7d after instilling the test sample. If no irritation occurs at 72h, the test can be terminated. If the cornea is found to be involved or there are other eye irritations, and if it does not recover within 7 days, the observation time should be extended to determine the reversibility or irreversibility of the damage, generally not exceeding 21 days.
豚鼠皮肤致敏试验步骤参考家兔急性皮肤刺激性试验步骤。For the skin sensitization test procedure on guinea pigs, refer to the rabbit acute skin irritation test procedure.
毒理学测试结果:抗菌液体A-J的毒理学试验均表明家兔一次皮肤刺激试验家兔皮肤一次接触该抗菌液体后,刺激积分值为0,皮肤损伤接触该消毒液,连续观察7天,伤口正常愈合,无发炎无红肿症状,属无刺激性;家兔一次眼刺激试验后,家兔眼粘膜(角膜、虹膜、结膜)刺激反应积分为0,属无刺激性;豚鼠皮肤致敏试验后24h、48h豚鼠皮肤试验区域均未见明显红斑及水肿出现,试样致敏率为0,按致敏强度分类,属弱致敏物(I级)。因此,可以认为本发明所述的抗菌湿巾所用抗菌液体安全无毒。Toxicological test results: The toxicological tests of antibacterial liquids A-J all showed that once the skin of rabbits was exposed to the antibacterial liquid in a skin irritation test, the stimulation integral value was 0, and the skin damage was exposed to the disinfectant. After continuous observation for 7 days, the wound was normal. Healing, no inflammation, no redness and swelling symptoms, it is non-irritating; after an eye irritation test in rabbits, the irritation reaction score of rabbit ocular mucosa (cornea, iris, conjunctiva) is 0, it is non-irritating; 24 hours after guinea pig skin sensitization test , 48h guinea pig skin test area, no obvious erythema and edema occurred, and the sensitization rate of the sample was 0, classified according to the sensitization intensity, and belonged to weak sensitizers (Class I). Therefore, it can be considered that the antibacterial liquid used in the antibacterial wet wipe of the present invention is safe and non-toxic.
将抗菌液体K-M按照同样的方法进行毒理学测试。测试结果分别为无皮肤刺激性,无眼睑刺激性,且属于弱致敏化学物品。The antibacterial liquid K-M is subjected to toxicological tests in the same way. The test results were no skin irritation, no eyelid irritation, and belonged to weak sensitizing chemicals.
该毒理学测试结果表明:尽管对比例所述抗菌液体也属于安全无毒无皮肤刺激性的消毒剂,但其抗菌效果不佳甚至没有抗菌性能,且壳聚糖仅能溶解于弱酸环境,因此实用价值不高。This toxicological test result shows: although the antibacterial liquid described in the comparative example also belongs to the disinfectant of safety, non-toxic and non-skin irritation, its antibacterial effect is not good or even does not have antibacterial performance, and chitosan can only be dissolved in weak acid environment, so The practical value is not high.
显然,本发明的上述实施例仅仅是为清楚地说明本发明所作的举例,而并非是对本发明的实施方式的限定,对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动,这里无法对所有的实施方式予以穷举,凡是属于本发明的技术方案所引伸出的显而易见的变化或变动仍处于本发明的保护范围之列。Apparently, the above-mentioned embodiments of the present invention are only examples for clearly illustrating the present invention, and are not intended to limit the implementation of the present invention. Those of ordinary skill in the art can also make It is impossible to exhaustively list all the implementation modes here, and any obvious changes or changes derived from the technical solutions of the present invention are still within the scope of protection of the present invention.
Claims (9)
- A kind of 1. safe and efficient antibacterial wet tissue, it is characterised in that:The antibacterial wet tissue is by sterilizing non-woven fabrics and is carried on sterilizing Chitosan derivatives base antibacterial liquid composition on non-woven fabrics, the load capacity of the antibacterial liquid is 50-500wt%;The antibacterial liquid includes the raw material of following parts by weight, in terms of 100 parts by weight:Chitosan derivatives 0.05-5 parts,Surfactant 0.5-5 parts,Deionized water surplus.
- A kind of 2. safe and efficient antibacterial wet tissue according to claim 1, it is characterised in that:The chitosan derivatives are Material shown in formula (1) and/or formula (2):In formula (1), x, y, n are natural number, 0 < x≤107, 0 < y≤107, 102≦n≦107;In formula (2), x, y, n are natural number, 0 < x≤5000,0 < y≤5000,10≤n≤5000.
- A kind of 3. antibacterial wet tissue of highly effective and safe according to claim 2, it is characterised in that:The system of formula (1) described material Preparation Method is as follows:1) chitosan is dissolved into water or dilute acid soln, through heating water bath and stirred, fully dissolving formed chitosan water or Dilute acid soln;2) between aqueous slkali regulation solution PH to 5~7;3) guanidinated reagent AminoiminomethanesulAcidc Acidc is slowly added into the water or dilute acid soln of chitosan, constant temperature is kept after addition Stirring 10 minutes~60 minutes;4) arginine activated solution is added into above-mentioned reaction solution, reacted 6~48 hours at a proper temperature;5) the hydroxylamine hydrochloride terminating reaction with arginine equimolar equivalent is added into reaction solution;6) dialysed after reacting liquid filtering with deionized water, then carry out freeze-drying process, that is, obtain product type (1) described thing Matter.
- A kind of 4. antibacterial wet tissue of highly effective and safe according to claim 2, it is characterised in that:The system of formula (2) described material Preparation Method is as follows:1) carboxymethyl chitosan is added to deionized water, be stirred at room temperature uniformly, form carboxymethyl chitosan sugar aqueous solution, it is standby;2) 2,3- epoxypropyltrimethylchloride chlorides are weighed, be dissolved in deionized water mix it is standby;3) under condition of heating and stirring, 2,3- epoxypropyltrimethylchloride chlorides solution by portions is added into carboxymethyl chitosan solution In, added in 2~8 hours, then constant temperature stirring is no more than 12 hours;4) after reaction terminates, question response product returns to room temperature, makes solution ph be 5.0~7.5 with cushioning liquid regulation, salt is dense Spend for 0.01~0.5M, obtain solution S 1;5) n-hydroxysuccinimide and 1- (3- dimethylamino-propyls) -3- ethyl-carbodiimide hydrochlorides are weighed, is dissolved in slow Solution is rushed, obtains solution S 2;6) weigh arginine or arginine oligomer thing is added to solution S 2 and activated, 20~50 DEG C of 1~5h of stirring, obtain solution S3;7) S3 solution by portions is added in solution S 1, is reacted 6~48 hours under condition of heating and stirring, obtain solution S 4;8) after reaction terminates, solution S 4 will be added with the hydroxylamine hydrochloride of arginine or arginine oligomer thing equimolar equivalent, with Terminating reaction;9) reaction product is filtered to remove insoluble matter, dialysed in deionized water, bag filter molecular cut off<10000Da, Freeze-drying process is then carried out, that is, obtains solid product formula (2) described material.
- A kind of 5. safe and efficient antibacterial wet tissue according to claim 1, it is characterised in that:The chitosan derivatives are also Including the one or more in material as follows:In formula (3), x, y, n are natural number, 0 < x≤5000,0 < y≤5000,1≤n≤30;In formula (4), X-For Cl-Or HSO3 -, x, n are natural number, 0 < x≤107, 102≦n≦107;In formula (5), x, n are natural number, 0 < x≤107, 10≤n≤107;In formula (6), x, n are natural number, 0 < x≤107, 102≦n≦107;In formula (7), x, n are natural number, 0 < x≤107, 102≦n≦107;In formula (8), X-For F-、Cl-、Br-、HSO4 -Or RCOO-, x, n are natural number, 0 < x≤107, 102≦n≦107;In formula (9), x, n are natural number, 0 < x≤107, 102≦n≦107;In formula (10), x, n are natural number, 0 < x≤107, 102≦n≦107;In formula (11), x, y, n are natural number, 0 < x≤107, 0 < y≤107, 102≦n≦107;In formula (12), X-For F-、Cl-、Br-、HSO4 -Or RCOO-, y, n are natural number, 0 < y≤107, 102≦n≦107;In formula (13), X-For F-、Cl-、Br-、HSO4 -Or RCOO-, y, n are natural number, 0 < y≤107, 102≦n≦107。
- A kind of 6. antibacterial wet tissue of highly effective and safe according to claim 5, it is characterised in that:The system of formula (3) described material Preparation Method is as follows:1) weigh carboxymethyl chitosan and add deionized water, be stirred at room temperature uniformly, form carboxymethyl chitosan sugar aqueous solution, it is standby;2) n-hydroxysuccinimide and 1- (3- dimethylamino-propyls) -3- ethyl-carbodiimide hydrochlorides are weighed, is dissolved in slow Solution is rushed, obtains solution S 1;3) weigh arginine or arginine oligomer thing is added to solution S 1 and activated, 0.5~4h is stirred at room temperature, obtains solution S2;4) solution S 2 is added portionwise in carboxymethyl chitosan sugar aqueous solution, reacts 6~48 hours, obtain under condition of heating and stirring To solution S 3;5) after reaction terminates, solution S 3 will be added with the hydroxylamine hydrochloride of arginine or arginine oligomer thing equimolar equivalent, with end Only react;6) reaction product is dialysed in deionized water, bag filter molecular cut off<5000Da, then it is freeze-dried Processing, that is, obtain solid product formula (3) described material.
- A kind of 7. antibacterial wet tissue of highly effective and safe according to claim 5, it is characterised in that:The system of formula (11) described material Preparation Method is as follows:1) carboxymethyl chitosan is dissolved into deionized water, through heating water bath and stirred, fully dissolving forms carboxymethyl chitosan The aqueous solution of sugar;2) guanidinated reagent AminoiminomethanesulAcidc Acidc is slowly added into the aqueous solution of carboxymethyl chitosan, constant temperature is kept after addition Stirring 10 minutes~60 minutes;3) arginine activated solution is added into above-mentioned reaction solution, reacted 6~48 hours at a proper temperature;4) the hydroxylamine hydrochloride terminating reaction with arginine equimolar equivalent is added into reaction solution;5) dialysed after reacting liquid filtering with deionized water, then carry out freeze-drying process, that is, obtain product type (11) described thing Matter.
- A kind of 8. antibacterial wet tissue of highly effective and safe according to claim 1, it is characterised in that:The surfactant is to tell In warm series of products, triethanolamine, ethoxylated alkyl sulfate, laureth sodium sulfovinate, stearic acid and its derivative One or more.
- 9. the preparation method of the antibacterial wet tissue of the highly effective and safe as described in claim 1-8 is any, it is characterised in that including as follows Preparation process:1) according to 100 parts by weight meters, the chitosan derivatives of 0.05-5 parts by weight is weighed and the surface of 0.5-5 parts by weight is lived Property agent, be added in the deionized water of residuals weight number, be sufficiently stirred be completely dissolved chitosan derivatives to become clarification saturating Bright solution, you can obtain chitosan derivatives base antibacterial liquid;2) sterilizing nonwoven is arranged in above-mentioned antibacterial liquid and soaks 5-10 minutes at room temperature.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610414752.1A CN107496176A (en) | 2016-06-14 | 2016-06-14 | Safe and efficient antibacterial wet tissue and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610414752.1A CN107496176A (en) | 2016-06-14 | 2016-06-14 | Safe and efficient antibacterial wet tissue and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107496176A true CN107496176A (en) | 2017-12-22 |
Family
ID=60678461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610414752.1A Pending CN107496176A (en) | 2016-06-14 | 2016-06-14 | Safe and efficient antibacterial wet tissue and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107496176A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111317706A (en) * | 2020-04-24 | 2020-06-23 | 云南伦扬科技有限公司 | Wet tissue with moisturizing, moistening and sterilizing functions and preparation method thereof |
CN111329827A (en) * | 2020-04-28 | 2020-06-26 | 江苏惠兴康科技有限公司 | Long-acting antibacterial disinfection wet tissue |
CN114561802A (en) * | 2022-01-26 | 2022-05-31 | 冠和卫生用品有限公司 | Natural antibacterial non-woven fabric and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102617753A (en) * | 2011-12-30 | 2012-08-01 | 华侨大学 | Inexpensive simple separation and purification method for quaternized chitosan |
CN102839569A (en) * | 2012-08-02 | 2012-12-26 | 翔瑞(泉州)纳米科技有限公司 | Chitosan wet tissue paper and preparation method thereof |
CN103628306A (en) * | 2013-12-09 | 2014-03-12 | 科凯精细化工(上海)有限公司 | Chitosan single guanidine hydrochloride loaded nanometer titanium dioxide compound and preparation method thereof |
CN104490633A (en) * | 2014-11-28 | 2015-04-08 | 成都顺发消洗科技有限公司 | Skin mucous membrane disinfection wet wipe |
CN104523457A (en) * | 2014-11-13 | 2015-04-22 | 苏州威尔德工贸有限公司 | Antisepsis and anti-inflammation baby wet tissue and preparation method thereof |
-
2016
- 2016-06-14 CN CN201610414752.1A patent/CN107496176A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102617753A (en) * | 2011-12-30 | 2012-08-01 | 华侨大学 | Inexpensive simple separation and purification method for quaternized chitosan |
CN102839569A (en) * | 2012-08-02 | 2012-12-26 | 翔瑞(泉州)纳米科技有限公司 | Chitosan wet tissue paper and preparation method thereof |
CN103628306A (en) * | 2013-12-09 | 2014-03-12 | 科凯精细化工(上海)有限公司 | Chitosan single guanidine hydrochloride loaded nanometer titanium dioxide compound and preparation method thereof |
CN104523457A (en) * | 2014-11-13 | 2015-04-22 | 苏州威尔德工贸有限公司 | Antisepsis and anti-inflammation baby wet tissue and preparation method thereof |
CN104490633A (en) * | 2014-11-28 | 2015-04-08 | 成都顺发消洗科技有限公司 | Skin mucous membrane disinfection wet wipe |
Non-Patent Citations (5)
Title |
---|
BO XIAO等: "Preparation and characterization of antimicrobial chitosan-N-arginine with different degrees of substitution", 《CARBOHYDRATE POLYMERS》 * |
李灵等: "壳聚糖双胍盐酸盐抑菌剂的合成及在包装上的应用", 《包装工程》 * |
王红丽等: "壳聚糖单胍盐酸盐的合成及在羊毛抗菌整理工艺中的应用", 《毛纺科技》 * |
赵雪等: "壳聚糖单胍盐酸盐衍生物的合成及其抗菌性能研究", 《整染技术》 * |
黄勇: "壳聚糖及其胍基化衍生物的合成、表征及抗菌性能研究", 《中国优秀硕士学位论文全文数据库》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111317706A (en) * | 2020-04-24 | 2020-06-23 | 云南伦扬科技有限公司 | Wet tissue with moisturizing, moistening and sterilizing functions and preparation method thereof |
CN111329827A (en) * | 2020-04-28 | 2020-06-26 | 江苏惠兴康科技有限公司 | Long-acting antibacterial disinfection wet tissue |
CN114561802A (en) * | 2022-01-26 | 2022-05-31 | 冠和卫生用品有限公司 | Natural antibacterial non-woven fabric and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2698182C1 (en) | Polymer-based antimicrobial compositions and a method for use thereof | |
US10350219B2 (en) | Antimicrobial compositions and methods of making the same | |
CN107496439B (en) | A kind of chitosan derivative-based disinfectant and preparation method thereof | |
KR101555341B1 (en) | Antibiotic wet tissue, and manufacturing method thereof | |
CN103356738A (en) | Skin disinfection gel and its application | |
CN113491709B (en) | Multifunctional high-efficiency compound disinfectant and preparation method thereof | |
CN111297704B (en) | Foam disinfection composition with bactericidal and skin care functions, preparation method and use thereof | |
CN107496206A (en) | Chitosan derivative-based water-free hand sanitizer special for children and preparation method thereof | |
CN115624507B (en) | Mild bacteriostat, and preparation method and application thereof | |
CN102113981B (en) | A kind of non-rinsing pregnant woman's perineal medical care gel and preparation method thereof | |
CN111557938A (en) | Disinfectant for quickly damaging viral envelope | |
CN105079858A (en) | Liquid dressing capable of sterilizing and repairing wounds and production method of liquid dressing | |
CN107496176A (en) | Safe and efficient antibacterial wet tissue and preparation method thereof | |
CN114652767B (en) | Dairy cow nipple medicated bath agent and preparation method thereof | |
CN113080207B (en) | Process for preparing disinfectant | |
CN107744524B (en) | Iodine-containing tincture antibacterial gel and preparation method thereof | |
CN103860821A (en) | Broad-spectrum disinfectant composition | |
CN111419799A (en) | Liposome disinfection gel and preparation method thereof | |
CN112426377B (en) | Water-soluble antibacterial spray and application thereof | |
CN107496440B (en) | A kind of gynecological toiletries and preparation method thereof | |
CN108728261B (en) | Environment-friendly physical bacteriostatic lotion and application thereof | |
KR100749138B1 (en) | Functional wipes | |
CN115212122A (en) | Washing-free disinfection cleaning solution for skin and preparation method thereof | |
CN114762501A (en) | Nano chitosan zinc and preparation method and application thereof | |
CN114984077A (en) | Alcohol-free washing-free disinfection gel and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171222 |